Structure Therapeutics (GPCR) Hits 52-Week High on Weight Loss Treatment Trial

We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best performers on Monday. Structure Therapeutics soared to a new 52-week high on Monday after announcing stellar topline results from its ongoing clinical program to test the efficacy of its therapy candidate, aleniglipron, in obese patients with co-morbidity. At intra-day trading, the stock surged to its highest price of $94.90 before profit-taking persisted and tr ...